atamestane has been researched along with Prostatic Hyperplasia in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (31.25) | 18.7374 |
| 1990's | 11 (68.75) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goldschmidt, AJ; Tunn, UW | 1 |
| Andriole, GL; Keetch, DW | 1 |
| el Etreby, MF; Habenicht, UF | 3 |
| el Etreby, MF; Gormley, GJ; Imperato-McGinley, JL; Oesterling, JE; Roehrborn, CG; Schröder, FH; Tunn, UW | 1 |
| Gingell, JC; Knönagel, H; Kurth, KH; Tunn, UW | 1 |
| Ekman, P | 1 |
| Bartsch, G; el Etreby, MF; Habenicht, UF; Schröder, FH; Schweikert, HU; Senge, T; Tunn, UW | 1 |
| Arnold, J; Blom, JH; Ennemoser, O; Habenicht, UF; Horniger, W; Schröder, FH; Schulze, H; Schweikert, HU; Senge, T; Tunn, UW | 1 |
| el Etreby, MF | 1 |
| Bono, AV; Eickenberg, HU; Fletcher, MS; Fourcade, RO; Radlmaier, A; Reis Santos, JM; van Aubel, OG | 1 |
| Henderson, D | 1 |
| el Etreby, MF; Habenicht, UF; Henderson, D; Kerb, U; Nishino, Y | 1 |
| el Etreby, MF; Habenicht, UF; Neumann, F; Schwarz, K | 1 |
| el Etreby, MF; Ghoniem, G; Habenicht, UF; Lewis, R; Roberts, J | 1 |
4 review(s) available for atamestane and Prostatic Hyperplasia
| Article | Year |
|---|---|
The function and the role of aromatase inhibitors in the treatment of BPH.
Topics: Androgens; Androstenedione; Animals; Aromatase Inhibitors; Clinical Trials as Topic; Disease Models, Animal; Estrogens; Flutamide; Humans; Macaca fascicularis; Male; Prostate; Prostatic Hyperplasia | 1994 |
Endocrine therapies for BPH: scientific rationale, clinical results, and patient selection.
Topics: 5-alpha Reductase Inhibitors; Androgen Antagonists; Androgens; Androstenedione; Animals; Aromatase Inhibitors; Clinical Trials as Topic; Gonadotropin-Releasing Hormone; Hormones; Humans; Male; Models, Biological; Patient Selection; Prostate; Prostatic Hyperplasia | 1994 |
Management of benign prostatic hyperplasia with particular emphasis on aromatase inhibitors.
Topics: Androstenedione; Animals; Aromatase Inhibitors; Estradiol; Humans; Male; Prostatic Hyperplasia; Tamoxifen | 1993 |
Atamestane: an aromatase inhibitor for the treatment of benign prostatic hyperplasia. A short review.
Topics: Androgens; Androstenedione; Animals; Aromatase Inhibitors; Dogs; Estrogens; Female; Humans; Male; Ovary; Prostatic Hyperplasia; Receptors, Androgen; Receptors, Estrogen | 1993 |
3 trial(s) available for atamestane and Prostatic Hyperplasia
| Article | Year |
|---|---|
Placebo controlled double-blind study to test the efficacy of the aromatase inhibitor atamestane in patients with benign prostatic hyperplasia not requiring operation. The Schering 90.062 Study Group.
Topics: Aged; Androstenedione; Aromatase Inhibitors; Double-Blind Method; Humans; Male; Prospective Studies; Prostatic Hyperplasia | 1995 |
Endocrine therapy for benign prostatic hyperplasia in the 90's.
Topics: Androstenedione; Aromatase Inhibitors; Controlled Clinical Trials as Topic; Double-Blind Method; Enzyme Inhibitors; Finasteride; Humans; Male; Placebos; Prostatic Hyperplasia; Testolactone | 1995 |
Estrogen reduction by aromatase inhibition for benign prostatic hyperplasia: results of a double-blind, placebo-controlled, randomized clinical trial using two doses of the aromatase-inhibitor atamestane. Atamestane Study Group.
Topics: Aged; Androgens; Androstenedione; Aromatase Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Estrone; Humans; Male; Middle Aged; Placebos; Prostatic Hyperplasia | 1996 |
9 other study(ies) available for atamestane and Prostatic Hyperplasia
| Article | Year |
|---|---|
[Aromatase inhibitors in the medical treatment of benign prostatic hypertrophy].
Topics: Androstenedione; Aromatase Inhibitors; Humans; Male; Prostatic Hyperplasia | 1993 |
Medical therapy for benign prostatic hyperplasia.
Topics: Adrenergic alpha-Antagonists; Androstenedione; Aromatase Inhibitors; Finasteride; Gonadotropin-Releasing Hormone; Humans; Male; Prostatic Hyperplasia | 1995 |
Effects of estrogen deprivation on human benign prostatic hyperplasia.
Topics: Aged; Aged, 80 and over; Androstenedione; Aromatase Inhibitors; Estradiol; Estrone; Humans; Male; Middle Aged; Prostate; Prostatic Hyperplasia | 1993 |
Estrogens and benign prostatic hyperplasia: rationale for therapy with aromatase inhibitors.
Topics: Androstenedione; Animals; Aromatase Inhibitors; Estrogens; Humans; Male; Prostatic Hyperplasia | 1991 |
Aromatase inhibitors and benign prostatic hyperplasia.
Topics: Androstenedione; Animals; Aromatase Inhibitors; Gonadotropins, Equine; Humans; Kinetics; Male; Prostatic Hyperplasia; Species Specificity | 1986 |
Synergic inhibitory effects of the aromatase inhibitor 1-methyl-androsta-1, 4-diene-3, 17-dione and the antiandrogen cyproterone acetate on androstenedione-induced hyperplastic effects in the prostates of castrated dogs.
Topics: Androstenedione; Animals; Aromatase Inhibitors; Castration; Cyproterone; Cyproterone Acetate; Dogs; Drug Synergism; Drug Therapy, Combination; Male; Prostate; Prostatic Hyperplasia; Time Factors | 1987 |
Induction of estrogen-related hyperplastic changes in the prostate of the cynomolgus monkey (Macaca fascicularis) by androstenedione and its antagonization by the aromatase inhibitor 1-methyl-androsta-1,4-diene-3,17-dione.
Topics: Androstenedione; Animals; Aromatase Inhibitors; Disease Models, Animal; Estradiol; Macaca fascicularis; Male; Organ Size; Prostate; Prostatic Hyperplasia | 1987 |
Selective inhibition of androstenedione-induced prostate growth in intact beagle dogs by a combined treatment with the antiandrogen cyproterone acetate and the aromatase inhibitor 1-methyl-androsta-1,4-diene-3,17-dione (1-methyl-ADD).
Topics: Androgen Antagonists; Androstenedione; Animals; Aromatase Inhibitors; Cyproterone; Cyproterone Acetate; Dogs; Epididymis; Luteinizing Hormone; Male; Organ Size; Prostate; Prostatic Hyperplasia; Radioimmunoassay; Testis | 1989 |
Induction of metachromasia in experimentally induced hyperplastic/hypertrophic changes in the prostate of the cynomolgus monkey (Macaca fascicularis).
Topics: Androstenedione; Animals; Aromatase Inhibitors; Macaca fascicularis; Male; Prostate; Prostatic Hyperplasia; Staining and Labeling | 1989 |